Sortilin | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

24 results for “Sortilin”

Trials

View all 11 →

Utility of Sortilin as a Biomarker of Restenosis After Lower Extremity Endovascular Revascularization

207 participants · First posted Mar 8, 2023

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

50 participants · First posted Aug 12, 2026

Evaluation of the Fortilink IBF System With TETRAfuse Technology

119 participants · First posted Oct 9, 2018

Drugs

TH-1904

News

View all 12 →

Vesper Bio's VES001 Shows 95% Increase in Progranulin Levels in Phase Ib/IIa Trial for Frontotemporal Degeneration

Vesper Bio's VES001 Shows Promise in Phase 1 Trial for Frontotemporal Dementia

Vesper Bio's VES001 Shows Promise in Phase I Trial for Frontotemporal Dementia

Page 1 of 3